1. ACTR-21. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (AMP) NEWLY DIAGNOSED GLIOBLASTOMA (nGBM). (11th November 2019) Authors: Lassman, Andrew; Pugh, Stephanie; Wang, Tony; Aldape, Kenneth; Gan, Hui; Preusser, Matthias; Vogelbaum, Michael; Sulman, Erik; Won, Minhee; Zhang, Peixin; Moazami, Golnaz; Macsai, Marian; Gilbert, Mark; Bain, Earle; Blot, Vincent; Ansell, Peter; Samanta, Suvajit; Kundu, Madan; Seidel, Clemens; De... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTR-24. A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY. (11th November 2019) Authors: Khasraw, Mustafa; Leanne McDonald, Kerrie; Rosenthal, Mark; Lwin, Zarnie; Ashley, David; Wheeler, Helen; Barnes, Elizabeth; Foote, Matthew; Koh, Eng-Siew; Sulman, Erik; Back, Michael; Buckland, Michael; Sim, Hao-Wen; Fisher, Lauren; Leonard, Robyn; Hall, Merryn; Yip, Sonia; Simes, John Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-34. SINGLE AGENT ONC201 IN PREVIOUSLY-TREATED, PROGRESSIVE ADULT H3 K27M-MUTANT GLIOMA. (11th November 2019) Authors: Arrillaga-Romany, Isabel; Kurz, Sylvia; Sumrall, Ashley; Butowski, Nicholas; Harrison, Rebecca; DeGroot, John; Chi, Andrew; Sulman, Erik; Shonka, Nicole; Umemura, Yoshie; Odia, Yazmin; Mehta, Minesh; Iwamoto, Fabio; Leia Nghiemphu, P; Cloughesy, Timothy; Tarapore, Rohinton; Merdinger, Krystal; Os... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ATIM-37. PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RADIATION (HFRT) FOR ADULT PATIENTS WITH SECONDARILY TRANSFORMED IDH-MUTANT GLIOBLASTOMA (GBM). (11th November 2019) Authors: Kurz, Sylvia; Silverman, Joshua S; Hochman, Tsivia; Nayak, Lakshmi; Arrillaga-Romany, Isabel; Lee, Eudocia; Patel, Amie; Delara, Malcolm; Hsu, Fraustina; Imtiaz, Tooba; Magnelli, Lori; Taylor, Jennie; Cloughesy, Timothy; Sulman, Erik; Golfinos, John; Zagzag, David; Snuderl, Matija; Goldberg, Judi... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BSCI-12. COMPREHENSIVE GENOMIC ANALYSIS OF BRAIN METASTASES FROM MULTIPLE CANCER TYPES. (12th August 2019) Authors: Fukumura, Kazutaka; Mao, Xizeng; Song, Xingzhi; Fischer, Grant; Yang, Jie; Sulman, Erik; Davies, Michael; Zhang, Jianhua; Huse, Jason Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CBIO-08. DIRECTED NEURONAL DIFFERENTIATION IN GBM BY SUPPRESSION OF TAZ. Issue 11 (6th November 2017) Authors: Audia, Alessandra; Das, Arvid; Mukheef, Farah; Zhang, Ze-yan; Sulman, Erik; Bhat, Krishna Journal: Neuro-oncology Issue: Volume 19:Issue 11(2017)supplement 6 Page Start: vi34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CTNI-38. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. (14th November 2022) Authors: Buxton, Meredith; Alexander, Brian; Berry, Donald; Cavenee, Webster; Colman, Howard; de Groot, John; Ellingson, Benjamin; Gordon, Gary; Khasraw, Mustafa; Lassman, Andrew; Lee, Eudocia; Li, Wenbin; Lim, Michael; Mellinghoff, Ingo; Mikkelsen, Tom; Nelli, Apoorva; Perry, James; Sulman, Erik; Tanner,... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTNI-42. GENOME-WIDE DNA METHYLATION PATTERNS IN VERTU: A RANDOMIZED PHASE II TRIAL OF VELIPARIB, RADIOTHERAPY AND TEMOZOLOMIDE IN PATIENTS WITH MGMT-UNMETHYLATED GLIOBLASTOMA. (14th November 2022) Authors: Sim, Hao-Wen; Lwin, Zarnie; Barnes, Elizabeth; McDonald, Kerrie; Koh, Eng-Siew; Rosenthal, Mark; Foote, Matthew; Back, Michael; Wheeler, Helen; Buckland, Michael; Walsh, Kyle; Fisher, Lauren; Leonard, Robyn; Hall, Merryn; Ashley, David; Yip, Sonia; Simes, John; Sulman, Erik; Khasraw, Mustafa Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CTNI-51. NEUROCOGNITIVE FUNCTION (NCF) OUTCOMES OF RTOG FOUNDATION 3508: A PHASE 3 TRIAL OF ABT-414 WITH CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH EGFR-AMPLIFIED NEWLY DIAGNOSED GBM. (9th November 2020) Authors: Wefel, Jeffrey S; Won, Minhee; Lassman, Andrew; Stern, Yaakov; Wang, Tony; Aldape, Kenneth; Armstrong, Terri; Vogelbaum, Michael; Sulman, Erik; Moazami, Golnaz; Macsai, Marian; Gilbert, Mark; Bain, Earle; Blot, Vincent; Gan, Hui; Preusser, Matthias; Ansell, Peter; Samanta, Suvajit; Kundu, Madan; ... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CTNI-53. SINGLE ARM, OPEN-LABEL, MULTICENTER PHASE II STUDY OF THE RADIONUCLIDE 177LU-DOTATATE (LUTATHERA) IN ADULTS WITH ADVANCED INTRACRANIAL MENINGIOMA. (9th November 2020) Authors: Kurz, Sylvia; Zan, Elcin; Gurewitz, Jasone; Cordova, Christine; Troxel, Andrea B; Sawaged, Zacharia; Sevillano-Torres, Hector; Silverman, Joshua S; Snuderl, Matija; Zagzag, David; Golfinos, John; Kondziolka, Douglas; Sulman, Erik Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗